Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 10, Issue 4, Pages 529-542
Publisher
Wiley
Online
2012-01-20
DOI
10.1111/j.1538-7836.2012.04639.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prasugrel overcomes high on-clopidogrel platelet reactivity in chronic coronary artery disease patients more effectively than high dose (150 mg) clopidogrel
- (2011) Dimitrios Alexopoulos et al. AMERICAN HEART JOURNAL
- The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy
- (2011) Paul A. Gurbel et al. AMERICAN HEART JOURNAL
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High On-Treatment Platelet Reactivity After Prasugrel Loading Dose and Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes
- (2011) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity
- (2011) D. ALEXOPOULOS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Platelet function variability and non-genetic causes
- (2011) Serdar Farhan et al. THROMBOSIS AND HAEMOSTASIS
- Genetic variability in response to clopidogrel therapy and its clinical implications
- (2011) Matthias Freynhofer et al. THROMBOSIS AND HAEMOSTASIS
- Novel antiplatelet therapy
- (2010) Michael A. Gaglia et al. AMERICAN HEART JOURNAL
- Letter by Gurbel et al Regarding Article, “Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement”
- (2010) Paul A. Gurbel et al. CIRCULATION
- Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
- (2010) Dirk Sibbing et al. CIRCULATION
- Tacrolimus-eluting carbon-coated stents versus sirolimus-eluting stents for prevention of symptom-driven clinical end points
- (2010) J. M. Siller-Matula et al. Clinical Research in Cardiology
- Genetic variability in response to clopidogrel therapy: clinical implications
- (2010) K. Huber EUROPEAN HEART JOURNAL
- CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study
- (2010) A. M. Harmsze et al. EUROPEAN HEART JOURNAL
- Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations
- (2010) Rasmus S. Pedersen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
- (2010) Nicoline J. Breet JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Comparison of the VerifyNow P2Y12 Point-of-Care Device and Light Transmission Aggregometry to Monitor Platelet Function with Prasugrel and Clopidogrel: An Integrated Analysis
- (2010) Joseph A Jakubowski et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Genotyping
- (2010) Paul A. Gurbel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy
- (2010) Dominick J. Angiolillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
- (2010) Jean-Sébastien Hulot et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
- (2010) Willibald Hochholzer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
- (2010) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stent Thrombosis
- (2010) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis
- (2010) J. M. SILLER-MATULA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment
- (2010) Guillaume Paré et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of conventional aggregomerty with VASP for monitoring P2Y12-specifc platelet inhibition
- (2010) Dániel Aradi et al. PLATELETS
- Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients
- (2010) Emilia Antonucci et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin
- (2009) Christoph Varenhorst et al. AMERICAN HEART JOURNAL
- Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases
- (2009) Jolanta M Siller-Matula et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
- (2009) D. Sibbing et al. EUROPEAN HEART JOURNAL
- Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial
- (2009) Alan D. Michelson et al. EUROPEAN HEART JOURNAL
- Recent developments in clopidogrel pharmacology and their relation to clinical outcomes
- (2009) Paul A Gurbel et al. Expert Opinion on Drug Metabolism & Toxicology
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
- (2009) Dirk Sibbing et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel
- (2009) H. J. BOUMAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay
- (2009) J. M. SILLER-MATULA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation
- (2009) Jolanta M. Siller-Matula et al. THROMBOSIS RESEARCH
- Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
- (2008) Jolanta M. Siller-Matula et al. AMERICAN HEART JOURNAL
- Incidence of Coronary Stent Thrombosis Based on Academic Research Consortium Definitions
- (2008) Robert J. Applegate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention
- (2008) Giuseppe Patti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Calcium-Channel Blockers Reduce the Antiplatelet Effect of Clopidogrel
- (2008) Jolanta M. Siller-Matula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents
- (2008) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
- (2008) Jean-Philippe Collet et al. LANCET
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reproducibility and standardized reporting of the vasodilator-stimulated phosphoprotein phosphorylation assay
- (2008) Jolanta M. Siller-Matula et al. PLATELETS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More